Skip to main content

Find Clinical Trials

Home
Conditions
Flaviviridae Infections

Clinical trial condition

Flaviviridae Infections

Explore clinical trials studying Flaviviridae Infections. Study availability and eligibility vary by location and protocol.

2,144 public trials 77 recruiting studies

Refine in advanced search Browse all conditions

Flaviviridae Infections trial results

Completed

Observational,Prospective Study to Develop and Validate a Prognostic Tool to Optimize Therapy in Patients With HCV G1/4

NCT01884402

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Fundación Pública Andaluza para la Gestión de la investigación en salud de Sevilla (FISEVI) Seville, Sevilla, Spain

Fundación Pública Andaluza para la Gestión de la investigación en salud de Sevilla (FISEVI) Seville, Spain

View Trial Details

Completed

Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.

NCT00323804

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +17 more
Locations: CHU Brugmann Brussels, Belgium

Hôpital Bracops Brussels, Belgium

Hôpital Erasme Brussels, Belgium

Hôpital de Jolimont La Louvière, Belgium

View all 45 locations

View Trial Details

Completed

Antiviral Efficacy, Pharmacokinetics and Safety of BILN 2061 ZW in Patients With Cirrhosis and Chronic Hepatitis C

NCT02226939

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +16 more
Locations: Not specified

View Trial Details

Completed

Antiviral Efficacy, Pharmacokinetics and Safety of BILN 2061 ZW in Patients With Chronic Hepatitis C Virus Infection

NCT02226952

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

Comparison in Efficacy and Safety Between Interferon Alfacon-1 Alone and Concomitant Dosing With Ribavirin for the Treatment of Hepatitis C

NCT00239252

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Chubu Region, Japan

Chugoku Region, Japan

Kinki Region, Japan

Kyushu Region, Japan

View Trial Details

Completed

Drug Interaction Study of an OCP (Norethindrone (ND) Acetate and Ethinyl Estradiol (EE))With a Combination of Daclatasvir (DCV) Asunaprevir (ASV) and BMS-791325

NCT02103569

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Not specified

View Trial Details

Completed

A Follow-up Evaluation for Safety in Subjects Who Participated in a Phase 1 Study With BMS-986094 (INX-08189)

NCT01732848

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations: Local Institution Los Angeles, California, United States

Prism Research Saint Paul, Minnesota, United States

New Orleans Center For Clinical Research - Knoxville Knoxville, Tennessee, United States

Local Institution San Antonio, Texas, United States

View Trial Details

Completed

Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese Toddlers

NCT01188343

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +31 more
Locations: Taichung, Taiwan

Taipei, Taiwan

Taoyuan, Taiwan

View Trial Details

Completed

Effects of Anti-HIV Drugs on the Hepatitis C Virus (HCV) in Adults Infected With Both HCV and HIV

NCT00545558

Conditions: Blood-Borne Infections, Coinfection, Communicable Diseases, +18 more
Locations: General Clinical Research Center (GCRC), OH site Cincinnati, Ohio, United States

Virginia Commonwealth University, School of Medicine Richmond, Virginia, United States

View Trial Details

Completed

A Phase 3 Study of Telaprevir in Combination With Pegasys® and Copegus® in Treatment-Naive Subjects With Genotype 1 Hepatitis C Virus (HCV)

NCT00627926

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Birmingham, Alabama, United States

Birmingham, Alabama, United States

Phoenix, Arizona, United States

Fresno, California, United States

View all 116 locations

View Trial Details